• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Training Linked to Costly Brand Name Prescribing

Article

There is a link between low-value prescribing and graduate medical training, according to a study led by researchers at the Perelman School of Medicine at the University of Pennsylvania and published in the Journal of General Internal Medicine.

There is a link between low-value prescribing and graduate medical training, according to a study led by researchers at the Perelman School of Medicine at the University of Pennsylvania and published in the Journal of General Internal Medicine.

A study of 10,151 statin prescriptions across 4 sites found that physicians in training are twice as likely to order a costly brand-name statin when supervised by senior physicians who prefer those medications in their own practice.

"These findings provide early empirical evidence that low-value practices among physicians are transferred from teachers to trainees, highlighting the importance of re-design of graduate medical education," Kira Ryskina, MD, a general internal medicine fellow at Penn, said in a statement. "We observed considerable variation in the prescribing practices of both attending physicians and residents, suggesting room to improve cost-effectiveness."

The probability of a resident prescribing a costly brand-name statin increased from 22.6% for those supervised by physicians who mostly prescribed cheaper generics to 41.6% when they were supervised by an attending who mostly prescribed expensive brand name statins. A higher postgraduate year level was associated with brand-name prescribing.

Related Videos
Pat Van Burkleo
Video 1 - "Diagnosing and Understanding the Pathogenesis of Bronchiectasis"
Video 4 - "Challenges in Autoantibody Screening for Type 1 Diabetes"
Jeff Stark, MD, vice president, head of medical immunology, UCB
Video 7 - "Prior Authorization and Access to Targeted Treatment for Ph+ ALL Patients"
Video 7 - "Prior Authorization and Access to Targeted Treatment for Ph+ ALL Patients"
Video 6 - "Community Partnership: Increasing Public Awareness of CVD"
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.